CSIMarket
 


Acura Pharmaceuticals inc  (ACUR)
Other Ticker:  
 


Acura Pharmaceuticals Inc's EBITDA Margin by quarter

Trends, Rankings, Statistics



ACUR EBITDA Margin (Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Revenue Change -94.99 % -34.15 % -54.63 % -40.97 % -41.15 %
Seq. Revenue Change -86.67 % -55.95 % -4.81 % -10.31 % 75.12 %
Revenue In Millions $0.04 $0.27 $0.61 $0.64 $0.72
EBITDA Margin - -90 % -46 % -19.88 % -15.6 %
EBITDA Margin Total Ranking # 188 # # # #
EBITDA In Millions $0.05 $-0.24 $-0.28 $-0.13 $-0.11
Y / Y EBITDA Change - - - - -
Seq. EBITDA Change - - - - -


Commenting fourth Quarter 2021 EBITDA Margin
Despite the sequential Revenue deterioration in IV. Quarter of -86.67 % Acura Pharmaceuticals inc managed to reduce Operating Costs and turn into profitability by achiving a EBITDA of 0 compare to Operating Loss of $-0.24 millions realized in previous quarter. Company accomplished EBITDA Margin of 130.56 % above company average EBITDA Margin.

Observing fourth quarter 2021 results within Major Pharmaceutical Preparations industry 20 other companies have achieved higher EBITDA Margin. While EBITDA Margin overall ranking has deteriorated compare to previous quarter from to 188.
Learn about Operating Margin
ACUR's EBITDA Margin fourth quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 35
Overall # 185

EBITDA Margin Statistics
High Average Low
220.63 % 68.23 % 25.4 %
(Dec 31 2018)   (Mar 31 2017)




Other EBITDA Margin Profitability Ratios
ACUR's Cumulative EBITDA Margin
Major Pharmaceutical Preparations Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
ACUR's EBITDA Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for ACUR's Competitors
EBITDA Margin Profit Margin for Acura Pharmaceuticals Inc's Suppliers
EBITDA Margin Profit Margin for ACUR's Customers

You may also want to know
ACUR's Annual Growth Rates ACUR's Profitability Ratios ACUR's Asset Turnover Ratio ACUR's Dividend Growth
ACUR's Roe ACUR's Valuation Ratios ACUR's Financial Strength Ratios ACUR's EBITDA Growth
ACUR's Roa ACUR's Inventory Turnover Ratio ACUR's Growth Rates ACUR's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Dec 31 2021, within Major Pharmaceutical Preparations Industry EBITDA MarginDec 31 2021 MRQ EBITDADec 31 2021 MRQ Revenue
Janone Inc   326.94 %$ 14.634 $ 4.476 
Zogenix Inc   265.65 %$ 70.681 $ 26.607 
Plx Pharma Inc   226.75 %$ 3.610 $ 1.592 
Skinvisible Inc   178.44 %$ 0.316 $ 0.177 
Acura Pharmaceuticals inc  130.56 %$ 0.047 $ 0.036 
Redhill Biopharma Ltd   116.21 %$ 99.658 $ 85.757 
Sinovac Biotech Ltd  91.07 %$ 17,644.834 $ 19,374.904 
Siga Technologies Inc  81.49 %$ 94.002 $ 115.357 
Lipocine Inc   81.24 %$ 12.656 $ 15.580 
Arcus Biosciences Inc   79.67 %$ 282.443 $ 354.499 
Orgenesis Inc   79.15 %$ 5.455 $ 6.892 
Syndax Pharmaceuticals Inc   76.01 %$ 96.205 $ 126.576 
Iterum Therapeutics Plc  74.48 %$ 2.653 $ 3.562 
Clearside Biomedical Inc   73.01 %$ 18.754 $ 25.687 
Molecular Templates inc   69.09 %$ 12.411 $ 17.964 
Lftd Partners Inc   66.88 %$ 8.552 $ 12.788 
Maravai Lifesciences Holdings Inc   66.80 %$ 152.590 $ 228.444 
Abcellera Biologics Inc   63.66 %$ 88.680 $ 139.311 
Atea Pharmaceuticals Inc   63.06 %$ 121.189 $ 192.180 
Innoviva Inc   62.36 %$ 67.144 $ 107.680 
Xoma Corporation  61.56 %$ 22.594 $ 36.702 
Elicio Therapeutics Inc   57.87 %$ 15.011 $ 25.941 
Prestige Consumer Healthcare Inc   57.32 %$ 157.336 $ 274.470 
Dynavax Technologies Corporation  52.95 %$ 103.282 $ 195.070 
Ionis Pharmaceuticals Inc  52.94 %$ 232.956 $ 440.006 
Regeneron Pharmaceuticals Inc   52.35 %$ 2,592.000 $ 4,951.700 
Novartis Ag  50.96 %$ 26,948.000 $ 52,877.000 
Evotec Se  50.78 %$ 351.503 $ 692.198 
Xencor Inc  48.99 %$ 75.459 $ 154.016 
Vertex Pharmaceuticals Inc  45.86 %$ 950.385 $ 2,072.561 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com